AYRFLUMO
LIVE

Serial Number

98581144

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Jun 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AYRFLUMO Trademark

Serial Number: 98581144 • Registration: 7599584

AYRFLUMO is a trademark filed by GlaxoSmithKline Biologicals SA on June 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

June 3, 2024

Registration Date

December 10, 2024

Published for Opposition

October 8, 2024

Goods & Services

Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 10, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 8, 2024 NPUB
PUBLISHED FOR OPPOSITION
Oct 8, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 3, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 3, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 3, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 3, 2024 CNEA
ASSIGNED TO EXAMINER
Aug 24, 2024 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 14, 2024 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2024 NWOS
NEW APPLICATION ENTERED
Jun 3, 2024 NWAP